| Identification of a null allele of CYP2C9 in an African–American exhibiting toxicity to phenytoin RS Kidd, TB Curry, S Gallagher, T Edeki, J Blaisdell, JA Goldstein Pharmacogenetics and Genomics 11 (9), 803-808, 2001 | 346 | 2001 |
| Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9* 3 allele RS Kidd, AB Straughn, MC Meyer, J Blaisdell, JA Goldstein, JT Dalton Pharmacogenetics and Genomics 9 (1), 71-80, 1999 | 239 | 1999 |
| Traditional and novel predictors of classroom and clerkship success of pharmacy students RS Kidd, DA Latif American Journal of Pharmaceutical Education 67 (1/4), 860, 2003 | 77 | 2003 |
| Student evaluations: are they valid measures of course effectiveness? RS Kidd, DA Latif American Journal of Pharmaceutical Education 68 (3), 2004 | 69 | 2004 |
| Comparison of students' performance in and satisfaction with a clinical pharmacokinetics course delivered live and by interactive videoconferencing RS Kidd, MK Stamatakis American Journal of Pharmaceutical Education 70 (1), 2006 | 67 | 2006 |
| Comparison of the frequency of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in depressed versus nondepressed patients MH Lizer, RL Bogdan, RS Kidd Journal of Psychiatric Practice® 17 (6), 404-409, 2011 | 33 | 2011 |
| Frequency of CYP3A4, CYP3A5, CYP2C9, and CYP2C19 variant alleles in patients receiving clopidogrel that experience repeat acute coronary syndrome ML Brackbill, RS Kidd, AD Abdoo, JG Warner, AF Harralson Heart and vessels 24, 73-78, 2009 | 31 | 2009 |
| Student pharmacists' use and perceived impact of educational technologies SK Stolte, C Richard, A Rahman, RS Kidd American Journal of Pharmaceutical Education 75 (5), 92, 2011 | 29 | 2011 |
| CYP2C9 genetic polymorphisms and warfarin AR Redman, LJ Dickmann, RS Kidd, JA Goldstein, DM Ritchie, YY Hon Clinical and applied thrombosis/hemostasis 10 (2), 149-154, 2004 | 24 | 2004 |
| Prospective trial of a novel nomogram to achieve updated vancomycin trough concentrations AR Wesner, ML Brackbill, LL Coyle, RS Kidd Interdisciplinary Perspectives on Infectious Diseases 2013, 2013 | 22 | 2013 |
| Warfarin dosing in a patient with CYP2C9* 3* 3 and VKORC1-1639 AA genotypes M Johnson, C Richard, R Bogdan, R Kidd Case Reports in Genetics 2014, 2014 | 19 | 2014 |
| Relationships among student evaluations, instructor effectiveness, and academic performance SD Phipps, RS Kidd, DA Latif Pharmacy Education 6 (4), 2006 | 15 | 2006 |
| First report of warfarin dose requirements in patients possessing the CYP2C9* 12 allele TJ O'Brien, RS Kidd, CAH Richard, NH Ha, P Witcher, LV Tran, A Barbour, ... Clinica Chimica Acta 424, 73-75, 2013 | 13 | 2013 |
| Assessing Knowledge and Attitude about ebola in the US: a Cross Sectional Survey A Jamal, K Startsman, J Guy, R Pierce, A Ahmad, J Chang, R Kidd, ... Value in Health 18 (3), A246, 2015 | 10 | 2015 |
| Evaluation of genetic variations in organic cationic transporter 3 in depressed and nondepressed subjects N Hengen, MH Lizer, RS Kidd International Scholarly Research Notices 2011, 2011 | 9 | 2011 |
| Patient care services in independent community pharmacies: a descriptive report G Peacock, R Kidd, A Rahman Journal of the American Pharmacists Association 47 (6), 762-767, 2007 | 9 | 2007 |
| An incremental approach to incorporating case-based learning into pharmacy curricula RS Kidd, MS Johnson, DL Smith, ET Robison, DW Newton Pharmacy Education 3 (1), 2003 | 9 | 2003 |
| Development and evaluation of an iOS vancomycin clinical decision support software application WH Spires, A Wesner, RS Kidd Journal of Mobile Technology in Medicine 4 (2), 2-11, 2015 | 1 | 2015 |
| Frequency analysis and correlation of newer variants alleles of CYP2C9 and warfarin dose. R Kidd, M Johnson, C Richard, J Adkins, A Harralson JOURNAL OF CLINICAL PHARMACOLOGY 46 (9), 1085-1085, 2006 | 1 | 2006 |
| Frequency of the SLCO1B1 (rs4149056) polymoR. Ph. ism in Caucasians compared to Mexican Americans. R Kidd, T Wright PHARMACOTHERAPY 37 (6), E55-E56, 2017 | | 2017 |
